AstraZeneca PLC

AstraZeneca PLCverified

AZN

Price:

$76.9

Market Cap:

$238.43B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1993-05-12

Stock Exchange

NASDAQ

Ticker

AZN

The PE Ratio as of May 2024 (TTM) for AstraZeneca PLC (AZN) is 38.07

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current PE Ratio is 38.07. This represents a change of 3.65% compared to the average of 36.73 of the last 4 quarters.

AstraZeneca PLC (AZN) Historical PE Ratio (quarterly & annually)

How has AZN PE Ratio performed in the past?

The mean historical PE Ratio of AstraZeneca PLC over the last ten years is 190.88. The current 38.07 PE Ratio has changed 1.89% with respect to the historical average. Over the past ten years (40 quarters), AZN's PE Ratio was at its highest in in the June 2019 quarter at 208.30. The PE Ratio was at its lowest in in the June 2016 quarter at -6365.06.

Quarterly (TTM)
Annual

Average

190.88

Median

42.85

Minimum

19.75

Maximum

1.47K

AstraZeneca PLC (AZN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.49%

Maximum Annual PE Ratio = 1.47K

Minimum Annual Increase = -95.67%

Minimum Annual PE Ratio = 19.75

Quarterly (TTM)
Annual
YearPE RatioChange
202335.04-45.12%
202263.84-95.67%
20211.47K3.49%
202041.04-57.77%
201997.18117.60%
201844.6649.61%
201729.8551.11%
201619.75-34.98%
201530.38-57.83%
201472.04147.75%

AstraZeneca PLC (AZN) Average PE Ratio

How has AZN PE Ratio performed in the past?

The current PE Ratio of AstraZeneca PLC (AZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

524.62

5-year avg

342.42

10-year avg

190.88

AstraZeneca PLC (AZN) PE Ratio vs. Peers

How is AZN’s PE Ratio compared to its peers?

AstraZeneca PLC’s PE Ratio is greater than Novartis AG (13.75), greater than GSK plc (32.12), greater than Roche Holding AG (1.38), greater than Bristol-Myers Squibb Company (-14.49), greater than Sanofi (15.77), less than Merck & Co., Inc. (144.10), less than Gilead Sciences, Inc. (174.48), greater than Johnson & Johnson (9.68), less than AbbVie Inc. (49.12), less than Eli Lilly and Company (113.00), greater than Pfizer Inc. (-547.35), less than Amgen Inc. (44.51),

CompanyPE RatioMarket cap
13.75$200.68B
32.12$91.71B
1.38$211.73B
-14.49$89.25B
15.77$111.72B
144.10$332.28B
174.48$84.37B
9.68$372.17B
49.12$293.88B
113.00$731.81B
-547.35$162.29B
44.51$167.62B

Build a custom stock screener for AstraZeneca PLC (AZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AstraZeneca PLC's PE Ratio?

How is the PE Ratio calculated for AstraZeneca PLC (AZN)?

What is the highest PE Ratio for AstraZeneca PLC (AZN)?

What is the 3-year average PE Ratio for AstraZeneca PLC (AZN)?

What is the 5-year average PE Ratio for AstraZeneca PLC (AZN)?

How does the current PE Ratio for AstraZeneca PLC (AZN) compare to its historical average?